Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ceritinib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106854182B reveals a high-yield, one-pot synthesis for 2,5-dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine, offering significant cost reduction in API manufacturing.
Novel patent method ensures high purity and safety for Ceritinib intermediate manufacturing reducing costs and improving supply chain reliability significantly.
Patent CN118146138B reveals a safer, cost-effective synthesis for Ceritinib intermediates, eliminating palladium catalysts and high-pressure risks for reliable supply.